Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib versus placebo plus cisplatin/gemcitabine for advanced biliary tract cancer
ISRCTN34043997Phase 2Completed
- Sponsor
- University College London
- Start
- Apr 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in biliary cancer, gallbladder cancer and Ampullary cancer (AC) comparing Cediranib + cisplatin + gemcitabine with Placebo + cisplatin + gemcitabine (2 arms). Primary endpoint: Progression-free survival. Started Apr 2011; status: completed.
02
Drugs
cediranib
03
Conditions
biliary cancergallbladder cancerAmpullary cancer (AC)
Beyond the preview
Go deeper on ISRCTN34043997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34043997.